BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pediatric Endocrine Society - ECPv6.17.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://pedsendo.org
X-WR-CALDESC:Events for Pediatric Endocrine Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251117T170000
DTEND;TZID=America/New_York:20251117T180000
DTSTAMP:20250820T181525Z
CREATED:20250820T181525Z
LAST-MODIFIED:20250820T181525Z
UID:26059-1763398800-1763402400@pedsendo.org
SUMMARY:STOA: Ethics SIG\, Beyond the Protocol: Case-Based Exploration of Ethical Challenges in Pediatric Research
DESCRIPTION:Brief Description  \nCall for Research Ethics Cases! The PES Ethics SIG is seeking real-world cases to be discussed at our upcoming webinar on ethical challenges in pediatric research\, especially if in relation to pediatric endocrinology. Minimal preparation is needed — share your case and join a thoughtful\, case-based conversation.   \n All PES members\, especially fellows\, are encouraged to present! If selected\, you’ll introduce your case and the Ethics SIG will guide an interactive discussion of the ethical questions it raises.   \n Cases should be submitted to AndrewK716@gmail.com by October 31\, 2025. Not available to attend? You can still contribute! Submit a question or topic you’d like us to address.  \nLearning Objectives   \n\nIdentify common ethical dilemmas in pediatric clinical research \nApply ethical principles to real-world case scenarios \n Explore frameworks for ethically sound study design and participation\n\n Speaker Name(s)  \nPES Ethics SIG Chairs will lead the discussions in conjunction with participating speakers. 
URL:https://pedsendo.org/event/stoa-ethics-sig-beyond-the-protocol-case-based-exploration-of-ethical-challenges-in-pediatric-research/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251125T150000
DTEND;TZID=America/New_York:20251125T160000
DTSTAMP:20240916T145518Z
CREATED:20240916T145518Z
LAST-MODIFIED:20240916T145518Z
UID:27777-1764082800-1764086400@pedsendo.org
SUMMARY:Diabetes SIG Meeting
DESCRIPTION:The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. \nIf you’re interested in joining the Diabetes SIG\, click here. \nIf you need the meeting link\, please reach out to info@pedsendo.org.
URL:https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2025-11-25/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251129
DTEND;VALUE=DATE:20251201
DTSTAMP:20251006T195203Z
CREATED:20251006T195052Z
LAST-MODIFIED:20251006T195203Z
UID:26261-1764374400-1764547199@pedsendo.org
SUMMARY:Second Annual GPED Meeting
DESCRIPTION:Greetings from Global Pediatric Endocrinology and Diabetes! \nWe are delighted to share an important update for the Second Annual GPED\nMeeting\, taking place virtually on 29–30 November and 6–7 December 2025. \nThe full scientific program and speaker lineup are now available! This year’s\nmeeting brings together a distinguished group of experts\, clinicians\, and researchers\nfrom across the globe who are dedicated to advancing pediatric endocrine care\nin resource-limited settings. \nUnder the theme:\n“Optimizing Pediatric Endocrine Care in Resource-Limited Settings: Bridging\nAssays\, Technology\, Management\, and Clinical Practice” \nThe program features:\n• Keynote lectures from world leaders in pediatric endocrinology\n• Interactive symposia and case-based discussions\n• Practical sessions on laboratory assays\, affordable technologies\, and models\nof care\n• Oral and poster abstract presentations from low- and middle-income countries \nExplore the full program and meet our speakers on the official meeting site. \nDon’t miss your chance to participate:\n• Registration remains open at just 15 USD.\n• Group registrations for 10 USD per ticket (Min 5) available!  \nFor details on the schedule\, confirmed speakers\, and sessions\, visit the official meeting site. For inquiries or group registrations\, please contact us\nat gpedmeeting@gmail.com. \nWe look forward to welcoming you to this exciting global event! \nWarm regards\, \nThe GPED Annual Meeting Organizing Committee
URL:https://pedsendo.org/event/second-annual-gped-meeting/2025-11-29/
LOCATION:https://pedsendo.org/event/second-annual-gped-meeting/2025-11-29/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251204T120000
DTEND;TZID=America/New_York:20251204T130000
DTSTAMP:20251107T161336Z
CREATED:20251107T161336Z
LAST-MODIFIED:20251107T161336Z
UID:26411-1764849600-1764853200@pedsendo.org
SUMMARY:PES SEED Webinar: Congenital Adrenal Hyperplasia
DESCRIPTION:Date: Thursday\, December 4\, 2025\, 12:00 PM EST \nTitle: Congenital Adrenal Hyperplasia \nBrief Description: \nSEED lecture for medical students regarding CAH. \nLearning objectives: \n1. Discuss the adrenal steroidogenesis pathway\, and how enzymatic defects could lead to CAH\n2. Review clinical manifestations of CAH\n3. Discuss management of CAH\, and how it may differ dependent on associated gene mutation \nSpeaker: \nKaterina Nella\,\nAssistant Professor of Pediatrics\, Department of Pediatrics\,\nDivision of Diabetes and Endocrinology\,\nBaylor College of Medicine
URL:https://pedsendo.org/event/pes-seed-webinar-congenital-adrenal-hyperplasia/
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251206
DTEND;VALUE=DATE:20251208
DTSTAMP:20251006T195204Z
CREATED:20251006T195052Z
LAST-MODIFIED:20251006T195204Z
UID:26262-1764979200-1765151999@pedsendo.org
SUMMARY:Second Annual GPED Meeting
DESCRIPTION:Greetings from Global Pediatric Endocrinology and Diabetes! \nWe are delighted to share an important update for the Second Annual GPED\nMeeting\, taking place virtually on 29–30 November and 6–7 December 2025. \nThe full scientific program and speaker lineup are now available! This year’s\nmeeting brings together a distinguished group of experts\, clinicians\, and researchers\nfrom across the globe who are dedicated to advancing pediatric endocrine care\nin resource-limited settings. \nUnder the theme:\n“Optimizing Pediatric Endocrine Care in Resource-Limited Settings: Bridging\nAssays\, Technology\, Management\, and Clinical Practice” \nThe program features:\n• Keynote lectures from world leaders in pediatric endocrinology\n• Interactive symposia and case-based discussions\n• Practical sessions on laboratory assays\, affordable technologies\, and models\nof care\n• Oral and poster abstract presentations from low- and middle-income countries \nExplore the full program and meet our speakers on the official meeting site. \nDon’t miss your chance to participate:\n• Registration remains open at just 15 USD.\n• Group registrations for 10 USD per ticket (Min 5) available!  \nFor details on the schedule\, confirmed speakers\, and sessions\, visit the official meeting site. For inquiries or group registrations\, please contact us\nat gpedmeeting@gmail.com. \nWe look forward to welcoming you to this exciting global event! \nWarm regards\, \nThe GPED Annual Meeting Organizing Committee
URL:https://pedsendo.org/event/second-annual-gped-meeting/2025-12-06/
LOCATION:https://pedsendo.org/event/second-annual-gped-meeting/2025-12-06/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20251223T150000
DTEND;TZID=America/New_York:20251223T160000
DTSTAMP:20240916T145518Z
CREATED:20240916T145518Z
LAST-MODIFIED:20240916T145518Z
UID:27778-1766502000-1766505600@pedsendo.org
SUMMARY:Diabetes SIG Meeting
DESCRIPTION:The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. \nIf you’re interested in joining the Diabetes SIG\, click here. \nIf you need the meeting link\, please reach out to info@pedsendo.org.
URL:https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2025-12-23/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260108T190000
DTEND;TZID=America/New_York:20260108T200000
DTSTAMP:20251110T190132Z
CREATED:20251110T190132Z
LAST-MODIFIED:20251110T190132Z
UID:26433-1767898800-1767902400@pedsendo.org
SUMMARY:PES Webinar: Pediatric Hypertriglyceridemia: Case-Based Algorithms
DESCRIPTION:Thursday\, January 8\, 2026\, 7-8pET – State of the Art: Lipid SIG  \nSession Title: \n\n\n\n\n\n\n\nPediatric Hypertriglyceridemia: Case-Based Algorithms\n\n\n\n\n\n\n\n\n\n\n\n\nBrief Description:\n\n\nPediatric hypertriglyceridemia is a clinically significant and increasingly recognized condition with implications for both acute and long-term health. Pediatric endocrinologists play a key role in identifying\, stratifying\, and managing this lipid disorder\, which may range from mild elevations to life-threatening severe hypertriglyceridemia associated with pancreatitis. Given the complex interplay between genetic\, metabolic\, and secondary causes\, pediatric endocrine providers must be equipped with practical\, pathophysiology-based approaches to diagnosis and management. Early\, targeted intervention can prevent complications and reduce cardiovascular risk later in life. This case-based session will empower clinicians with actionable algorithms tailored to severity and etiology\, enhancing the precision of care for affected children and adolescents. \nLearning objectives:  \n\nEvaluate hypertriglyceridemia by severity and align first-line interventions with each tier.\nIllustrate a risk-stratified algorithm that matches interventions to underlying pathophysiology\nDistinguish monogenic severe hypertriglyceridemia from multifactorial/polygenic causes and tailor therapy accordingly.\n\nSpeaker:  \nAmbika P. Ashraf MD\, FAAP\, FNLA\nRalph Frohsin Endowed Chair in Pediatric Endocrinology\nDivision Director/ Pediatric Endocrinology and Diabetes\nAssociate Director\, Comprehensive Diabetes Center\nProfessor of Pediatrics/Heersink School of Medicine\nThe University of Alabama at Birmingham
URL:https://pedsendo.org/event/pes-webinar-pediatric-hypertriglyceridemia-case-based-algorithms/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260120T150000
DTEND;TZID=America/New_York:20260120T170000
DTSTAMP:20260120T144742Z
CREATED:20251111T134651Z
LAST-MODIFIED:20260120T144742Z
UID:26452-1768921200-1768928400@pedsendo.org
SUMMARY:PES Endo365 Webinar: Career Pathways for Pediatric Endocrine Fellows
DESCRIPTION:Tuesday\, January 20\, 2026\, 3-5p ET \nSession Title: \nCareer Pathways for Pediatric Endocrine Fellows\n \nBrief Description: \n\n\n\nThis activity addresses the following key concepts:\n1. Common viable career paths after fellowship training.\n2. Importance of identifying what paths match values\, skills\, and interests\n3. Role of networking in identifying mentors and job prospects.\n\n\n\n\n\n\nLearning Objectives: \n1. Describe the career pathways available after endocrine fellowship\n2. Identify what career pathway/s match your skills\, values\, and interests.\n3. Evaluate two possible career paths and the next steps needed via networking with professionals at various stages of a career in that track (clinician-scientist (basic/clinical)\, clinician-educator\, industry\, private practice) \nSpeakers & Moderators: \n\nNidhi Bansal\, Baylor College of Medicine\,\nKanthi Bangalore Krishna\, UPMC Childrens Hospital of Pittsburgh\nAmit Lahoti\, Nationwide Children’s Hospital\nKathleen Timme\, University of Utah\nRona Sonabend\, Baylor College of Medicine\, Texas Children’s Hospital\nAlissa Guarneri\, UPMC Children’s Hospital of Pittsburgh\nAristides Maniatis\, Rocky Mountain Pediatric Endocrinology\nG. Prakasam\, Sutter Health\nSonali Malhotra\, AstraZeneca\nGeorge Jeha\, Neurocrine Biosciences\, Inc.\nMary Ellen Vajravelu\, UPMC Children’s Hospital of Pittsburgh\nStephanie Sisley\, Baylor College of Medicine\, Texas Children’s Hospital\nJessica Schmitt\, Children’s Hospital of Alabama at UAB\nNamrata Kotwal\, Baylor College of Medicine\, Texas Children’s Hospital
URL:https://pedsendo.org/event/pes-endo365-webinar-career-pathways-for-pediatric-endocrine-fellows/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260120T190000
DTEND;TZID=America/New_York:20260120T200000
DTSTAMP:20251217T171232Z
CREATED:20251217T164816Z
LAST-MODIFIED:20251217T171232Z
UID:26658-1768935600-1768939200@pedsendo.org
SUMMARY:PES Turner Syndrome SIG: Book Club
DESCRIPTION:TS Journal Club\nWhen: Jan 20th\, 2026 @ 7PM Eastern\nWhere: Zoom\nTopic: TBA
URL:https://pedsendo.org/event/pes-turner-syndrome-sig-book-club/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260126T160000
DTEND;TZID=America/New_York:20260126T170000
DTSTAMP:20241121T191254Z
CREATED:20241002T184643Z
LAST-MODIFIED:20241121T191254Z
UID:24477-1769443200-1769446800@pedsendo.org
SUMMARY:Quarterly Education Committee Webinar: Updates in the treatment of hypoparathyroidism
DESCRIPTION:Date: Monday\, January 26\, 2026 / 4:00 pm – 5:00 pm EST \nTitle: Updates in the treatment of hypoparathyroidism \nDescription: Discussion on Hypoparathyroidism diagnosis and treatment \nLearning objectives: \n\nUnderstand the role of parathyroid hormone and the calcium-sensing receptor in mineral metabolism and how derangements can lead to hypocalcemia\nUnderstand the use of conventional therapy for the treatment of hypoparathyroidism and its limitations\nUnderstand mechanism of novel therapeutics for the treatment of hypoparathyroidism\n\nSpeaker: \nRachel I. Gafni\, MD\, FASBMR \nSenior Research Physician Skeletal Disorders and Mineral Homeostasis Section \nNational Institute of Dental and Craniofacial Research \nNational Institutes of Health \n\n\n\n\n\nRegister Here
URL:https://pedsendo.org/event/quarterly-education-committee-webinar-updates-in-the-treatment-of-hypoparathyroidism/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260127T150000
DTEND;TZID=America/New_York:20260127T160000
DTSTAMP:20240916T145518Z
CREATED:20240916T145518Z
LAST-MODIFIED:20240916T145518Z
UID:27779-1769526000-1769529600@pedsendo.org
SUMMARY:Diabetes SIG Meeting
DESCRIPTION:The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. \nIf you’re interested in joining the Diabetes SIG\, click here. \nIf you need the meeting link\, please reach out to info@pedsendo.org.
URL:https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2026-01-27/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260127T170000
DTEND;TZID=America/New_York:20260127T180000
DTSTAMP:20251111T133832Z
CREATED:20251111T133745Z
LAST-MODIFIED:20251111T133832Z
UID:26449-1769533200-1769536800@pedsendo.org
SUMMARY:PES Hypoglycemia SIG Webinar: Demystifying the Fasting Test
DESCRIPTION:Tuesday\, January 27\, 2026\, 5-6pET – State of the Art: Hypoglycemia SIG \nSession Title: \nDemystifying the Fasting Test \nBrief Description:\nThe diagnostic evaluation of an infant or child that presents with hypoglycemia is a critical step for establishing the specific diagnosis and treatment. This evaluation relies on obtaining a “critical sample” during a spontaneous episode of hypoglycemia or at the end of diagnostic fast. Fasting tests are also performed to establish the efficacy of the treatment\, or the resolution of the hypoglycemia after definitive treatment. During this webinar we will review the practical aspects of performing these different fasting tests\, the interpretation of the results\, and the safety of the procedure. \nLearning objectives: \n\nTo review the indications for diagnostic\, safety\, and cure fasting tests\nTo outline the differences between diagnostic\, safety and cure fasting tests\nTo review the interpretation of data obtained during diagnostic\, safety and cure fasting tests\n\nSpeakers: \nKatherine Lord\, MD\nChildren’s Hospital of Philadelphia \nPaul Thornton\, MD\nCook Children’s Medical Center
URL:https://pedsendo.org/event/26449/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260203T120000
DTEND;TZID=America/New_York:20260203T130000
DTSTAMP:20260209T175539Z
CREATED:20250818T181201Z
LAST-MODIFIED:20260209T175539Z
UID:26046-1770120000-1770123600@pedsendo.org
SUMMARY:Understanding the impact of bias and stigma on children affected by obesity
DESCRIPTION:Tuesday\, February 3\, 2026\, 12-1pET – State of the Art: Obesity SIG & HSD Committee \nSession Title: Understanding the impact of bias and stigma on children affected by obesity \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nBrief Description:\n\n\nBias and stigma have been shown to be common experiences of individuals affected by obesity. Understanding the impact of bias and stigma on children. the role of internalized stigma and how to recognize it\, as well as the interventions identified or proposed to improve the outcomes for our patients will be discussed. \nLearning objectives:  \n\nDescribe how weight bias affects the emotional and physical health of children and adolescents.\n2. Explain the role of families—particularly parents—in shaping youth experiences of weight stigma.\nIdentify practical strategies pediatric clinicians can use to reduce weight bias in patient care for youth with higher weight.\n\nSpeaker:  \nRebecca Puhl\, PhD Professor\, Human Development & Family Sciences Deputy Director\, Rudd Center for Food Policy & Health University of Connecticut 
URL:https://pedsendo.org/event/understanding-the-impact-of-bias-and-stigma-on-children-affected-by-obesity/
CATEGORIES:SIG Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260205T180000
DTEND;TZID=America/New_York:20260205T190000
DTSTAMP:20260123T193134Z
CREATED:20251107T195343Z
LAST-MODIFIED:20260123T193134Z
UID:26415-1770314400-1770318000@pedsendo.org
SUMMARY:PES Turner Syndrome SIG Webinar: Prenatal Counseling for Turner Syndrome
DESCRIPTION:Thursday\, February 5\, 2026\, 6-7pET – State of the Art: Turner Syndrome SIG \nSession Title: Prenatal Counseling for Turner Syndrome \nBrief Description: \nSpeaker will discuss prenatal genetic counseling strategies and spectrum in Turner syndrome. Case based discussion. \nLearning Objectives   \n\nUnderstand the landscape and principles of genetic counseling for prenatal diagnoses of Turner syndrome\nApplication of these principles in a case based format\nReview post-natal genetic testing\n\n  \nSpeaker Name(s)  \nWendy Brickman\, MD \nSusan Howell\, MBA\, MS\, CGC
URL:https://pedsendo.org/event/pes-turner-syndrome-sig-webinar-prenatal-counseling-for-turner-syndrome/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260209T120000
DTEND;TZID=America/New_York:20260209T130000
DTSTAMP:20260519T214044Z
CREATED:20250821T150935Z
LAST-MODIFIED:20260519T214044Z
UID:26066-1770638400-1770642000@pedsendo.org
SUMMARY:PES APP SIG Meeting
DESCRIPTION:For more information on the APP SIG\, click here. \nTo join a SIG\, click here.
URL:https://pedsendo.org/event/pes-app-sig-meeting-2/2026-02-09/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260209T160000
DTEND;TZID=America/New_York:20260209T170000
DTSTAMP:20251113T141306Z
CREATED:20251111T141531Z
LAST-MODIFIED:20251113T141306Z
UID:26463-1770652800-1770656400@pedsendo.org
SUMMARY:PES Bone&Mineral Webinar: New\, Disruptive Precision Therapies for Achondroplasia: Changing the Rules of the Game
DESCRIPTION:Monday\, February 9\, 2026\, 4-5pET – State of the Art: Bone and Mineral SIG \nSession Title: New\, Disruptive Precision Therapies for Achondroplasia: Changing the Rules of the Game \nBrief Description: \nThis presentation will discuss newly approved and emerging pharmacotherapies for the treatment of achondropDISABLEDlasia. Special attention will be given to potential benefits of these treatments on clinically important and patient centered outcomes beyond stature including quality of life and sequelae of spinal stenosis\, foramen magnum stenosis\, and other orthopedic manifestations of this condition. Given the recent approval of vosoritide and anticipated approval of other pharmacotherapies targeting the FGFR3 pathway for the treatment of achondropDISABLEDlasia\, we anticipate that this topic will be of interest to a wide range of the PES community who will be participating in the care of these individuals. \nLearning Objectives   \n\nUnderstand the pathophysiology underlying achondroplasia\nLearn how the current and emerging pharmacotherapies for achondroplasia target the FGFR3 pathway\nBecome familiar with possible benefits of treatment on outcomes beyond height\n\n  \nSpeaker Name(s)  \nProfessor Ravi Savarirayan\,\nInterventional Clinical Geneticist\,\nMurdoch Children’s Research Institute\,\nUniversity of Melbourne\, Parkville\, Victoria\, Australia
URL:https://pedsendo.org/event/pes-bonemineral-webinar-new-disruptive-precision-therapies-for-achondroplasia-changing-the-rules-of-the-game/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260211T103000
DTEND;TZID=America/New_York:20260211T113000
DTSTAMP:20260123T144634Z
CREATED:20260120T163458Z
LAST-MODIFIED:20260123T144634Z
UID:26817-1770805800-1770809400@pedsendo.org
SUMMARY:Industry Sponsored Symposium: Exploring Innovative Pathways for Congenital Hyperinsulinism Treatment Pioneering Pathways to Better Health
DESCRIPTION:Industry Sponsored Symposium:\nExploring Innovative Pathways for Congenital Hyperinsulinism Treatment Pioneering Pathways to Better Health \nWednesday\, February 11\, 2026 at 10:30 am – 11:30 am ET \nDescription:\nCongenital hyperinsulinemia (CHI) is a complex and serious disorder that most often appears in newborns and young infants as prolonged\, often severe\, hypoglycemia. When diagnosis or treatment is delayed or inadequate\, infants face a real risk of irreversible neurological damage\, therefore\, timely recognition and prompt intervention are essential. \nCurrent medical and surgical options are limited\, leaving many families with few effective choices. New therapies on the horizon may change that landscape — offering options for easier administration\, less frequent dosing\, improved tolerability\, and with a promise of reduced frequency and duration of hypoglycemia. \nJoin our live webinar where leading experts will confront the critical gaps in CHI care\, review real patient cases and outcomes\, and evaluate both established treatments and emerging therapies. You’ll gain practical\, evidence-based insights to improve early detection\, optimize management\, and better support families affected by this challenging disease. \nCME/CNE available. \nModerator: ​​ \nJulie Raskin\, ​Chief Executive Officer\, ​Congenital Hyperinsulinism International\, Glen Ridge\, New Jersey​ \nSpeaker: \nDiva D. De Leon Crutchlow\, MD\, MSCE\, Division Chief: Endocrinology and Diabetes Children’s Hospital of Philadelphia Professor of Pediatrics University of Pennsylvania Philadelphia\, Pennsylvania \nPaul S. Thornton\, MD\, ​Division Chief\, Endocrinology and Diabetes\, Cook Children’s Medical Center\, ​Fort Worth\, Texas​ \nSponsored by: Supported by an independent educational grant from Zealand Pharma A/S.
URL:https://pedsendo.org/event/industry-sponsored-symposium-exploring-innovative-pathways-for-congenital-hyperinsulinism-treatment-pioneering-pathways-to-better-health/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260211T120000
DTEND;TZID=America/New_York:20260211T130000
DTSTAMP:20251110T165405Z
CREATED:20251110T164100Z
LAST-MODIFIED:20251110T165405Z
UID:26418-1770811200-1770814800@pedsendo.org
SUMMARY:PES SEED Webinar: Calcium Pathophysiology/Management
DESCRIPTION:Date: Wednesday\, February 11\, 2026\, 12:00 PM EST \nTitle: Calcium Pathophysiology/Management \nBrief Description: \nSEED lecture for medical students re calcium\, speaker Monica Grover from Stanford \nLearning objectives: \n1. Describe common conditions that can impact calcium and phosphorus physiology\n2. Review the impacts of parathyroid hormone and vitamin D on calcium physiology\n3. Discuss management strategies for acute and chronic hypocalcemia and hypercalcemia \n Speaker: \nMonica Grover\nClinical Associate Professor of Pediatrics\,\nDivision of Endocrinology and Diabetes\nStanford University School of Medicine
URL:https://pedsendo.org/event/pes-seed-webinar-calcium-pathophysiology-management/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260211T160000
DTEND;TZID=America/New_York:20260211T170000
DTSTAMP:20260130T185324Z
CREATED:20260130T184439Z
LAST-MODIFIED:20260130T185324Z
UID:26925-1770825600-1770829200@pedsendo.org
SUMMARY:PES Ethics SIG: Beyond the Algorithm: Ethical AI in Pediatric Endocrinology
DESCRIPTION:Wednesday\, February 11\, 2026\, 4-5pET – State of the Art: Ethics SIG \nSession Title: Beyond the Algorithm: Ethical AI in Pediatric Endocrinology \nBrief Description: \nArtificial intelligence is rapidly transforming how we practice medicine—from clinical decision support and documentation to patient communication and diagnostic reasoning. As pediatric endocrinologists\, we face unique opportunities and challenges as these tools enter our workflows. How do we integrate AI responsibly? Where are the risks? And what does ethical practice look like when humans and algorithms collaborate? \nJoin the Ethics SIG for a dynamic conversation on the ethical implications of AI in pediatric endocrinology\, guided by Kelly Michelson\, MD\, MPH\, FCCM\, FAAP\, HEC-C—Professor of Pediatrics\, Julia & David Uihlein Professor of Bioethics and Medical Humanities\, Director of the Center for Bioethics and Medical Humanities\, and Chief Ethics Officer for the Institute for Augmented Intelligence in Medicine at Northwestern University Feinberg School of Medicine. \nThis session will explore how AI can support care\, where it may hinder it\, and how pediatric endocrinologists can navigate these rapidly evolving tools with clarity\, caution\, and creativity. \nLearning Objectives   \n\nIdentify current and emerging uses of AI relevant to pediatric endocrine practice.\nAnalyze ethical challenges and potential biases in AI tools\, particularly as they affect children and adolescents with endocrine disorders.\nEvaluate real-world scenarios illustrating how AI may shape clinical judgment\, patient communication\, and provider responsibility.\nApply practical strategies for incorporating AI into practice while preserving professionalism\, patient trust\, and equitable care.\n\n  \nSpeaker Name(s)  \nKelly Michelson\, MD\, MPH\, FCCM\, FAAP\, HEC-C
URL:https://pedsendo.org/event/pes-ethics-sig-beyond-the-algorithm-ethical-ai-in-pediatric-endocrinology/
CATEGORIES:SIG Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260218T130000
DTEND;TZID=America/New_York:20260218T140000
DTSTAMP:20251219T193221Z
CREATED:20251113T151043Z
LAST-MODIFIED:20251219T193221Z
UID:26499-1771419600-1771423200@pedsendo.org
SUMMARY:PES DSD SIG Webinar: Gonadal Management in DSD
DESCRIPTION:Wednesday\, February 18\, 2026\, 1-2pET – State of the Art: DSD SIG \nSession Title: Gonadal Management in DSD \nBrief Description: \nIndividuals with various forms of differences of sex development (DSD) may be at increased risk of developing gonadal germ cell cancer. This risk depends on several factors including the presence of the gonadoblastoma region on the Y chromosome\, gonadal location\, degree of gonadal dysgenesis\, degree of germ cell development and age\, but only limited data are available on cancer incidence\, especially in adulthood. This presentation will go into assessment of gonadal cancer risk as well as gonadal function. Current options for gonadal monitoring will be reviewed\, acknowledging their limitations. Individuals with DSD and their families should be counseled about the options for gonadal monitoring or prophylactic gonadectomy to allow shared decision making regarding gonadal management; tools have been developed to facilitate this process. \nLearning Objectives   \n\nDifferentiate between gonads at higher or lower risk for gonadal germ cell cancer in individuals with DSD\nCompare the potential benefits and harms or risks of gonadal monitoring versus prophylactic gonadectomy\nSummarize the steps of shared decision-making regarding gonadal management\n\n  \nSpeaker Name(s)  \nSabine Hannema\, MD\, PhD \nDepartment of Paediatric Endocrinology\, \nEmma Children’s Hospital\, Amsterdam UMC\, \nAmsterdam\, the Netherlands
URL:https://pedsendo.org/event/pes-dsd-sig-webinar-management-of-the-risky-gonad-in-individuals-with-dsd/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260224T150000
DTEND;TZID=America/New_York:20260224T160000
DTSTAMP:20240916T145518Z
CREATED:20240916T145518Z
LAST-MODIFIED:20240916T145518Z
UID:27780-1771945200-1771948800@pedsendo.org
SUMMARY:Diabetes SIG Meeting
DESCRIPTION:The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. \nIf you’re interested in joining the Diabetes SIG\, click here. \nIf you need the meeting link\, please reach out to info@pedsendo.org.
URL:https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2026-02-24/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260226T170000
DTEND;TZID=America/New_York:20260226T180000
DTSTAMP:20260218T200658Z
CREATED:20251113T143002Z
LAST-MODIFIED:20260218T200658Z
UID:26480-1772125200-1772128800@pedsendo.org
SUMMARY:PES Thyroid SIG Webinar\, Pediatric Thyroid US Series - Session 1 - Normal Thyroid US
DESCRIPTION:Thursday\, February 26\, 2026\, 5-6pET – State of the Art: Thyroid SIG \nSession Title: Pediatric Thyroid US Series – Session 1 – Normal Thyroid US \nBrief Description: \nThis is a 3 part series on the Pediatric Thyroid US. This first session is focused on Normal Thyroid US. \nLearning Objectives   \n\nIdentify features of normal thyroid anatomy and normal variations (e.g.\, intrathyroidal thymus)\nIdentify features of normal thyroid anatomy (e.g.\, intrathyroidal thymus) and normal variations\nDescribe features of autoimmune thyroid conditions and differentiate nodules from pseudonodules\nPractical tips for incorporating thyroid US into daily endocrine practice\n\nSpeaker Name(s)  \nDr. Andrew Bauer
URL:https://pedsendo.org/event/pes-thyroid-sig-webinar-pediatric-thyroid-us-series-1-normal-thyroid-us/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260303T120000
DTEND;TZID=America/New_York:20260303T130000
DTSTAMP:20251110T170319Z
CREATED:20251110T165324Z
LAST-MODIFIED:20251110T170319Z
UID:26421-1772539200-1772542800@pedsendo.org
SUMMARY:PES SEED Webinar: Evaluation and Management of Common Endocrine Emergencies
DESCRIPTION:Date: Tuesday\, March 3\, 2026\, 12:00 PM EST \nTitle: Evaluation and Management of Common Endocrine Emergencies \nBrief Description: \nSEED talk re endocrine emergencies \nLearning objectives: \n1. Review emergent medical conditions of endocrine origin\n2. Discuss the evaluation for endocrine emergencies\, including which clinical presentations raise concern for an endocrine emergency\n3. Describe management of endocrine emergencies \n Speaker: \nNancie MacIver\nAssociate Professor of Pediatrics\, Nutrition\, and Microbiology/Immunology\nDivision Chief\, Pediatric Endocrinology\nUniversity of North Carolina at Chapel Hill
URL:https://pedsendo.org/event/26421/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260311T150000
DTEND;TZID=America/New_York:20260311T160000
DTSTAMP:20260218T173108Z
CREATED:20260218T173108Z
LAST-MODIFIED:20260218T173108Z
UID:27089-1773241200-1773244800@pedsendo.org
SUMMARY:Industry Sponsored Symposium: Real-World Patient and Clinical Perspectives: Preparing Your Pediatric Patients for Successful Care Transitions in Classic Congenital Adrenal Hyperplasia
DESCRIPTION:Industry Sponsored Symposium:\nReal-World Patient and Clinical Perspectives: Preparing Your Pediatric Patients for Successful Care Transitions in Classic Congenital Adrenal Hyperplasia\n \nWednesday\, March 11\, 2026 at 3:00 – 4:00pm ET\nSponsored by Neurocrine BioSciences \nDescription:\nFeaturing insights from a patient\, caregiver\, and an expert healthcare provider and researcher\, this presentation highlights the clinical and practical challenges involved in the lifelong management of classic congenital adrenal hyperplasia. The speakers will share valuable takeaways from their own experiences navigating the transition from pediatric to adult endocrinology care. \nAttendees will learn about the risks associated with transitions of care\, including adrenal crisis and gaps in disease management\, and discover strategies for early planning\, patient empowerment\, and standardized hand-off protocols. \nSpeakers: \nLeslie Pitts\, DNP-PhD(c)\, CPNP-AC\, AP-PEN\nUniversity of Alabama at Birmingham\nSchool of Nursing \nKevin\nA 26-year-old living with classic congenital adrenal hyperplasia and patient ambassador \nTrish\nKevin’s mother and caregiver ambassador \nSponsored by: Neurocrine BioSciences
URL:https://pedsendo.org/event/industry-sponsored-symposium-real-world-patient-and-clinical-perspectives-preparing-your-pediatric-patients-for-successful-care-transitions-in-classic-congenital-adrenal-hyperplasia/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260311T190000
DTEND;TZID=America/New_York:20260311T200000
DTSTAMP:20260203T213508Z
CREATED:20260203T213508Z
LAST-MODIFIED:20260203T213508Z
UID:26948-1773255600-1773259200@pedsendo.org
SUMMARY:PES State of the Art Webinar;  Incorporating patient advocates into the DSD/Intersex Multidisciplinary Clinics
DESCRIPTION:Wednesday\, March 11\, 2026\, 7-8pET – State of the Art: DSD SIG \nSession Title: Incorporating patient advocates into the DSD/Intersex Multidisciplinary Clinics \nBrief Description: \nThis session will focus on the incorporation of patient advocates into the Intersex/DSD multidisciplinary clinics. The session will be open to members of PES and members of the Society of Pediatric Psychology. It will be lead by Cindy Buchanan\, PhD and Noi Liang\, MBA\, BCPA who have developed a patient advocate program. Our goals are to help Intersex/DSD multidisciplinary clinics develop a patient advocate programs and to continue facilitate the collaboration between pediatric endocrinologist\, pediatric psychologists\, and patient advocates. \nLearning Objectives   \n\nDescribe the role of the patient advocates in intersex/DSD MDC and Identify ways to engage patients and care givers\nUnderstand steps for identifying and training patient advocates\nReview the experience of the patient advocate\n\nSpeaker Name \nCindy Buchanan\, PhD \nNoi Liang\, MBA\, BCPA
URL:https://pedsendo.org/event/pes-state-of-the-art-webinar-incorporating-patient-advocates-into-the-dsd-intersex-multidisciplinary-clinics/
CATEGORIES:SIG Webinar
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260316T160000
DTEND;TZID=America/New_York:20260316T170000
DTSTAMP:20250818T200222Z
CREATED:20250818T200222Z
LAST-MODIFIED:20250818T200222Z
UID:26051-1773676800-1773680400@pedsendo.org
SUMMARY:Quarterly Education Webinar: Thyroid cancer in children and adolescents
DESCRIPTION:Date: Monday\, March 16\, 2026 / 4:00 pm – 5:00 pm EST \nTitle: Thyroid cancer in children and adolescents\n \nDescription: This session will review thyroid cancer in children and adolescents. \nLearning objectives: \n\nDiscuss the epidemiology and genetics of thyroid cancer in children\nDiscuss diagnosis of thyroid cancer in children\nExplain current approaches to thyroid cancer treatment in children\n\nSpeaker: \nAri Wassner\, MD; Harvard Medical School\, Boston Children’s Hospital
URL:https://pedsendo.org/event/quarterly-education-webinar-thyroid-cancer-in-children-and-adolescents/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260321T080000
DTEND;TZID=America/New_York:20260325T163000
DTSTAMP:20251105T142459Z
CREATED:20251027T165819Z
LAST-MODIFIED:20251105T142459Z
UID:26332-1774080000-1774456200@pedsendo.org
SUMMARY:Clinical Endocrinology 2026 Course
DESCRIPTION:The objective of this course is to provide an update for endocrinologists and to allow internists and other health care providers to be comfortable with clinical problems in endocrinology. A faculty of 49 speakers\, primarily Harvard Medical School faculty and several select outside experts\, chosen for their recognized educational and communication skills\, present the most up-to-date\, evidence-based approach to endocrine problems such as osteoporosis\, type 1 and type 2 diabetes\, hypercholesterolemia\, pituitary tumors\, menopause\, thyroid abnormalities\, and reproductive dysfunction\, as well as a broad spectrum of other clinical problems in endocrinology\, such as obesity. Each day is organized around one of the major topics to be covered: pituitary disease on Saturday; calcium and bone disorders on Sunday; diabetes and metabolic disorders on Monday; reproductive and adrenal disorders on Tuesday; thyroid disease on Wednesday. Special emphasis is given to the case study method in 90-minute problem sessions on Sunday\, Monday\, and Tuesday. Two of these sessions will include a nurse or nurse practitioner to provide a nursing perspective on the topic. A comprehensive syllabus is provided; all companies providing educational grants are acknowledged in the syllabus and thanked during the Welcome & Introduction session. \nFor more than 50 years\, this update in Endocrinology has been presented by the faculty of the Endocrine Division of Massachusetts General Hospital\, joined by guest speakers from around the country. Attendees have participated from over 50 US states and territories\, and over 60 other countries. The virtual livestream format enhances access to the course for international health care providers. Course participants are asked to fill out an extensive evaluation form that covers all aspects of the course. \nLink for faculty\, learning objectives and more information – https://learn.hms.harvard.edu/endocrinology \nCME- earn up to 40.5 AMA PRA Category 1 Credits™\, ABIM MOC points\, ANCC contact hours\, AAPA Category 1 Credits\, and ECME Credits
URL:https://pedsendo.org/event/an-invitation-from-the-harvard-medical-school-massachusetts-general-hospital-clinical-endocrinology-2026-course/
LOCATION:https://pedsendo.org/event/an-invitation-from-the-harvard-medical-school-massachusetts-general-hospital-clinical-endocrinology-2026-course/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260324T150000
DTEND;TZID=America/New_York:20260324T160000
DTSTAMP:20240916T145518Z
CREATED:20240916T145518Z
LAST-MODIFIED:20240916T145518Z
UID:27781-1774364400-1774368000@pedsendo.org
SUMMARY:Diabetes SIG Meeting
DESCRIPTION:The Diabetes SIG mission: To promote prevention and support excellence in the treatment of pediatric diabetes and its comorbidities. \nIf you’re interested in joining the Diabetes SIG\, click here. \nIf you need the meeting link\, please reach out to info@pedsendo.org.
URL:https://pedsendo.org/event/diabetes-sig-t1dm-subgroup-meeting/2026-03-24/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260324T150000
DTEND;TZID=America/New_York:20260324T170000
DTSTAMP:20260311T143435Z
CREATED:20260203T213729Z
LAST-MODIFIED:20260311T143435Z
UID:26950-1774364400-1774371600@pedsendo.org
SUMMARY:PES TREND SIG & PedsEndo 365 Webinar: Evaluation and Management of Tumor Related Endocrine and Neuroendocrine Disorders
DESCRIPTION:Tuesday\, March 24\, 2026\, 3-5pET – State of the Art: TREND SIG & PedsEndo 365 \nSession Title: \nEvaluation and Management of Tumor Related Endocrine and Neuroendocrine Disorders\nBrief Description: \nIn collaboration with the Tumor Related Endocrine and Neuroendocrine Disorders (“TREND”) SIG\, the PedsEndo365 aims to improve increased awareness of late effects observed in childhood cancer and brain tumor survivors through a case-based workshop for pediatric endocrinology fellows. \nLearning Objectives   \n\nUnderstand the complex interplay between hypothalamic disruption associated with intracranial radiation with or without surgery\nDescribe the effect/s of chemotherapy on gonadal function in both males and females\nDiscuss the mechanisms by which tyrosine kinase inhibitors and immune check point inhibitors impact the endocrine system\n\nSpeaker Name \n\nPriyanka Bakhtiani\nKanthi Bangalore Krishna\nNidhi Bansal\nWassim Chemaitilly\nLaurie Cohen\nPallavi Iyer\nAmit Lahoti\nMaya Lodish\nAlison Murray\nJessica Schmidt\nCarmen L. Soto-Rivera
URL:https://pedsendo.org/event/pes-trend-sig-pedsendo-365-webinar-evaluation-and-management-of-dsd/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20260407T180000
DTEND;TZID=America/New_York:20260407T190000
DTSTAMP:20260305T140522Z
CREATED:20260305T140522Z
LAST-MODIFIED:20260305T140522Z
UID:27237-1775584800-1775588400@pedsendo.org
SUMMARY:PES Hypoglycemia SIG Meeting
DESCRIPTION:Mission Statement \nHypoglycemia disorders are rare\, but their consequences in children can be severe and have a lasting impact. The PES Hypoglycemia Disorders Special Interest Group (SIG) aims to improve the diagnosis and management of infants and children with hypoglycemia disorders through education\, clinical care standardization\, research and advocacy. \n  \nTo Learn more about the SIG\, click here. \nTo join the SIG\, click here.
URL:https://pedsendo.org/event/pes-hypoglycemia-sig-meeting/
END:VEVENT
END:VCALENDAR